Product How it works Pricing Blog FAQ About Contact
Acadia Pharmaceuticals

Acadia Pharmaceuticals (NASDAQ: ACAD) net income

Acadia Pharmaceuticals reported a net profit of $391.0m for fiscal 2025, 72.7% more than in fiscal 2024 ($226.5m). Its net margin was 36.5%. Earnings per share were $2.32.

Fiscal 2025 is the highest of the 10 fiscal years on record for Acadia Pharmaceuticals. It reported a loss in 8 of those 10 years.

Net income, in millions of US dollars-271.42016-289.42017-245.22018-235.32019-281.62020-167.92021-216.02022-61.32023226.52024391.02025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Net income by fiscal year

Fiscal yearNet incomeChangeNet marginEarnings per share
2025$391.0m+72.7%36.5%$2.32
2024$226.5m—23.6%$1.37
2023−$61.3m—−8.4%−$0.37
2022−$216.0m—−41.8%−$1.34
2021−$167.9m—−34.7%−$1.05
2020−$281.6m—−63.7%−$1.79
2019−$235.3m—−69.4%—
2018−$245.2m—−109.6%—
2017−$289.4m—−231.7%—
2016−$271.4m—−1,565.9%—

The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Acadia Pharmaceuticals net income compared with its sector

By net income for its latest fiscal year, Acadia Pharmaceuticals ranks 68th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Acadia Pharmaceuticals, 36.5%.

RankCompanyNet incomeNet margin
66thHenry Schein$398.0m3.0%
67thAptarGroup$392.8m10.4%
68thAcadia Pharmaceuticals$391.0m36.5%
69thCooper Companies$374.9m9.2%
70thRigel Pharmaceuticals$367.0m124.7%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.

Questions about the net income of Acadia Pharmaceuticals

How much did Acadia Pharmaceuticals earn in fiscal 2025?
Acadia Pharmaceuticals reported a net profit of $391.0m for fiscal 2025. In fiscal 2024 it reported a net profit of $226.5m.
What are the earnings per share of Acadia Pharmaceuticals?
They were $2.32 in fiscal 2025, compared with $1.37 in fiscal 2024.
What is the net margin of Acadia Pharmaceuticals?
In fiscal 2025 its net profit was 36.5% of its revenue.
What was the most profitable year for Acadia Pharmaceuticals?
Of its last 10 fiscal years, fiscal 2025, with $391.0m.
Where does Acadia Pharmaceuticals rank in its sector by net income?
It ranks 68th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
Where do the figures for Acadia Pharmaceuticals come from?
From the annual report (Form 10-K) that Acadia Pharmaceuticals files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Acadia Pharmaceuticals files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Acadia Pharmaceuticals: the Acadia Pharmaceuticals page · annual accounts · revenue · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.